Circulating alpha-klotho levels are not disturbed in patients with type 2 diabetes with and without macrovascular disease in the absence of nephropathy

Cardiovascular Diabetology

Volumn 12, Issue 1, 2013, Pages

  van Ark, Joris ^a   Hammes, Hans Peter ^b   van Dijk, Marcory C R F ^a,c   Vervloet, Marc G ^d   Wolffenbuttel, Bruce H R ^a   van Goor, Harry ^a   Hillebrands, Jan Luuk ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c RIJNSTATE HOSPITAL   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Atherosclerosis; Coronary artery disease; Klotho; Macrovascular disease; Peripheral artery disease; Type 2 diabetes

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; GLUCOSE; HEMOGLOBIN A1C; KLOTHO PROTEIN; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HBA(1C) PROTEIN, MOUSE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; KIDNEY TUBULE EPITHELIUM; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROTEIN EXPRESSION; UREA NITROGEN BLOOD LEVEL; AGED; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL CULTURE; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; GLUCOSE BLOOD LEVEL; KIDNEY TUBULE; METABOLISM; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK FACTOR; TIME;

AGED; ANIMALS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELLS, CULTURED; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY TUBULES; MALE; MICE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; RNA, MESSENGER; TIME FACTORS;

EID: 84883174903     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-12-116     Document Type: Article

References (18)

1. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 2002, 287(19):2570-2581. 10.1001/jama.287.19.2570, 12020339.
2. Kuro-o M. Klotho and aging. Biochim Biophys Acta 2009, 1790(10):1049-1058. 10.1016/j.bbagen.2009.02.005, 2743784, 19230844.
3. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E, Iwasaki H, Iida A, Shiraki-Iida T, Nishikawa S, Nagai R, Nabeshima YI. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 1997, 390(6655):45-51. 10.1038/36285, 9363890.
4. Saito Y, Yamagishi T, Nakamura T, Ohyama Y, Aizawa H, Suga T, Matsumura Y, Masuda H, Kurabayashi M, Kuro-o M, Nabeshima Y, Nagai R. Klotho protein protects against endothelial dysfunction. Biochem Biophys Res Commun 1998, 248(2):324-329. 10.1006/bbrc.1998.8943, 9675134.
5. Maekawa Y, Ohishi M, Ikushima M, Yamamoto K, Yasuda O, Oguro R, Yamamoto-Hanasaki H, Tatara Y, Takeya Y, Rakugi H. Klotho protein diminishes endothelial apoptosis and senescence via a mitogen-activated kinase pathway. Geriatr Gerontol Int 2011, 11(4):510-516. 10.1111/j.1447-0594.2011.00699.x, 21518171.
6. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW. Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 2011, 22(1):124-136. 10.1681/ASN.2009121311, 3014041, 21115613.
7. Semba RD, Cappola AR, Sun K, Bandinelli S, Dalal M, Crasto C, Guralnik JM, Ferrucci L. Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc 2011, 59(9):1596-1601. 10.1111/j.1532-5415.2011.03558.x, 3486641, 21883107.
8. John GB, Cheng CY, Kuro-o M. Role of Klotho in aging, phosphate metabolism, and CKD. Am J Kidney Dis 2011, 58(1):127-134. 10.1053/j.ajkd.2010.12.027, 3191324, 21496980.
9. Asai O, Nakatani K, Tanaka T, Sakan H, Imura A, Yoshimoto S, Samejima K, Yamaguchi Y, Matsui M, Akai Y, Konishi N, Iwano M, Nabeshima Y, Saito Y. Decreased renal alpha-Klotho expression in early diabetic nephropathy in humans and mice and its possible role in urinary calcium excretion. Kidney Int 2012, 81(6):539-547. 10.1038/ki.2011.423, 22217880.
10. Devaraj S, Syed B, Chien A, Jialal I. Validation of an immunoassay for soluble Klotho protein: decreased levels in diabetes and increased levels in chronic kidney disease. Am J Clin Pathol 2012, 137(3):479-485. 10.1309/AJCPGPMAF7SFRBO4, 22338062.
11. Kacso IM, Bondor CI, Kacso G. Soluble serum Klotho in diabetic nephropathy: relationship to VEGF-A. Clin Biochem 2012, 45(16-17):1415-1420.
12. Yamazaki Y, Imura A, Urakawa I, Shimada T, Murakami J, Aono Y, Hasegawa H, Yamashita T, Nakatani K, Saito Y, Okamoto N, Kurumatani N, Namba N, Kitaoka T, Ozono K, Sakai T, Hataya H, Ichikawa S, Imel EA, Econs MJ, Nabeshima Y. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: Age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun 2010, 398(3):513-518. 10.1016/j.bbrc.2010.06.110, 20599764.
13. van Ark J, Moser J, Lexis CP, Bekkema F, Pop I, van der Horst IC, Zeebregts CJ, van Goor H, Wolffenbuttel BH, Hillebrands JL. Type 2 diabetes mellitus is associated with an imbalance in circulating endothelial and smooth muscle progenitor cell numbers. Diabetologia 2012, 55(9):2501-2512. 10.1007/s00125-012-2590-5, 3411291, 22648662.
14. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612. 10.7326/0003-4819-150-9-200905050-00006, 2763564, 19414839, CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration).
15. Heijboer AC, Levitus M, Vervloet MG, Lips P, ter Wee PM, Dijstelbloem HM, Blankenstein MA. Determination of fibroblast growth factor 23. Ann Clin Biochem 2009, 46(Pt 4):338-340.
16. de Borst MH, Vervloet MG, ter Wee PM, Navis G. Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. J Am Soc Nephrol 2011, 22(9):1603-1609. 10.1681/ASN.2010121251, 3171931, 21852584.
17. Chen CD, Podvin S, Gillespie E, Leeman SE, Abraham CR. Insulin stimulates the cleavage and release of the extracellular domain of Klotho by ADAM10 and ADAM17. Proc Natl Acad Sci U S A 2007, 104(50):19796-19801. 10.1073/pnas.0709805104, 2148378, 18056631.
18. Seiler S, Wen M, Roth HJ, Fehrenz M, Flugge F, Herath E, Weihrauch A, Fliser D, Heine GH. Plasma Klotho is not related to kidney function and does not predict adverse outcome in patients with chronic kidney disease. Kidney Int 2013, 83(1):121-128. 10.1038/ki.2012.288, 22895520.